首页> 外国专利> Modelling in yeast of the mitochondrial ATP6 gene mutations responsible for NARP syndrome in humans and uses thereof for screening for medicaments

Modelling in yeast of the mitochondrial ATP6 gene mutations responsible for NARP syndrome in humans and uses thereof for screening for medicaments

机译:酵母中负责人NARP综合征的线粒体 ATP6 基因突变的建模及其在药物筛选中的用途

摘要

Modified yeast cells comprising at least one mutation of the tryptophan 136 (W136), leucine 183 (L183), or leucine 247 (L247) codon of the mitochondrial ATP6 gene, responsible for NARP syndrome in humans and uses thereof for screening for medicaments that act against mitochondrial pathologies involving a deficiency in ATP production via the oxidative phosphorylation pathway, such as NARP syndrome.
机译:修饰的酵母细胞,包含至少一个色氨酸136(W 136 ),亮氨酸183(L 183 )或亮氨酸247(L 247 >)负责人类NARP综合征的线粒体ATP6基因的密码子,并用于筛选与线粒体病理学有关的药物,该药物涉及通过氧化磷酸化途径导致ATP生成不足的线粒体病理学,例如NARP综合征。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号